PXD101 potentiates hormonal therapy and prevents the onset of castration-resistant phenotype modulating androgen receptor, HSP90, and CRM1 in preclinical models of prostate cancer
Endocrine Related Cancer (2013) - Comments
pubmed: 23507703  doi: 10.1530/erc-12-0240  issn: 1479-6821  issn: 1351-0088 

Giovanni Luca Gravina, Francesco Marampon, Paola Muzi, Andrea Mancini, Margherita Piccolella, Paola Negri-Cesi, Marcella Motta, Andrea Lenzi, Ernesto Di Cesare, Vincenzo Tombolini, Emmanuele A Jannini, Claudio Festuccia